Page last updated: 2024-12-06

pirimicarb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pirimicarb: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pirimicarb : An aminopyrimidine that is N,N,4,5-tetramethylpyrimidin-2-amine substituted by a (dimethylcarbamoyl)oxy group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID31645
CHEMBL ID1870931
CHEBI ID8248
SCHEMBL ID26523
MeSH IDM0058684

Synonyms (80)

Synonym
carbamic acid, dimethyl-, 2-(dimethylamino)-5,6-dimethyl-4-pyrimidinyl ester
epa pesticide chemical code 106101
abol
pirimor granulate
rapid
pirimor g
brn 0663442
aficida
pyrimor
ent-27766
hsdb 7005
fernos
pirimicarb [ansi:bsi:iso]
5,6-dimethyl-2-dimethylamino-4-pyrimidinyldimethylcarbamate
pirimor
einecs 245-430-1
caswell no. 359c
primicarbe
2-(dimethylamino)-5,6-dimethyl-4-pyrimidinyldimethylcarbamate
pp 062
ai3-27766
5,6-dwumetylo-2-dwumetyloamino-4-pirimidynylodwukarbaminian [polish]
aphox
pirimor 50 dp
pirimicarbe [iso-french]
dimethylcarbamic acid 2-(dimethylamino)-5,6-dimethyl-4-pyrimidinyl ester
2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamate
CHEBI:8248 ,
5,6-dimethyl-2-dimethylamino-4-dimethylcarbamoyloxypyrimidine
23103-98-2
pirimicarb
NCGC00163704-01
NCGC00163704-02
FT-0655935
yfgyufniohwbob-uhfffaoysa-
inchi=1/c11h18n4o2/c1-7-8(2)12-10(14(3)4)13-9(7)17-11(16)15(5)6/h1-6h3
(2-dimethylamino-5,6-dimethylpyrimidin-4-yl) n,n-dimethylcarbamate
[2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl] n,n-dimethylcarbamate
NCGC00163704-03
NCGC00254905-01
dtxcid9012569
cas-23103-98-2
tox21_301003
dtxsid1032569 ,
[2-(dimethylamino)-5,6-dimethyl-pyrimidin-4-yl] n,n-dimethylcarbamate
A816567
5-25-13-00063 (beilstein handbook reference)
unii-1i93ps935t
2-(dimethylamino)-5,6-dimethyl-4-pyrimidinyl dimethylcarbamate
pirimicarbe
5,6-dwumetylo-2-dwumetyloamino-4-pirimidynylodwukarbaminian
1i93ps935t ,
2-dimethylamino-5,6-dimethyl-4-pyrimidinyl dimethylcarbamate
AKOS015892522
CHEMBL1870931
pirimicarb [hsdb]
2-(dimethylamino)-5,6-dimethyl-4-pyrimidinyl n,n-dimethylcarbamate
pirimicarb [mi]
2-dimethylamino-5,6-dimethylpyrimidin-4-yl dimethylcarbamate
pirimicarb [iso]
SCHEMBL26523
carbamic acid, dimethyl-, 2-(dimethylamino)-5,6-dimethyl-4-pyrimidyl ester
pyrimicarbe
oms 1330
YFGYUFNIOHWBOB-UHFFFAOYSA-N
GS-3028
2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl n,n-dimethylcarbamate
pirimicarb, pestanal(r), analytical standard
pirimicarb 100 microg/ml in acetonitrile
pirimicarb 100 microg/ml in cyclohexane
pirimicarb 10 microg/ml in acetonitrile
J-014990
2-dimethylamino-5,6-dimethylpyrimidin-4-yl n,n-dimethylcarbamate
Q419705
mfcd00055520
HY-119419
CS-0068146
pirimicarb 1000 microg/ml in acetone
H10475
dimethyl-carbamic acid 2-dimethylamino-5,6-dimethyl-pyrimidin-4-yl ester

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These pesticides are highly toxic to humans and their residues in food pose potential threat to human health."( Combined subchronic toxicity of dichlorvos with malathion or pirimicarb in mice liver and serum: a metabonomic study.
Li, L; Li, W; Liang, YJ; Sun, YJ; Wang, HP; Wang, P; Wu, YJ; Xu, MY; Yang, L, 2014
)
0.64

Compound-Compound Interactions

ExcerptReferenceRelevance
"Experiments were carried out in the laboratory to assess the insecticidal effect on Myzus persicae Sulzer of different oils applied alone or combined with imidacloprid or pirimicarb."( Use of oils combined with low doses of insecticide for the control of Myzus persicae and PVY epidemics.
Cabaleiro, C; Marnotes, S; Martín-López, B; Varela, I, 2006
)
0.53

Bioavailability

ExcerptReferenceRelevance
" The reduced bioavailability of pirimicarb may derive from humic acid and related compounds released from the sediment."( Bioavailability and effect of pirimicarb on Daphnia magna in a laboratory freshwater/sediment system.
Kusk, KO, 1996
)
0.87

Dosage Studied

Dose-response bioassays were conducted to determine relative tolerances to the insecticides pirimicarb, dimethoate, and imidacloprid.

ExcerptRelevanceReference
" Dosing studies confirmed pirimicarb as the causative agent and the anaemia was characterised as haemolytic."( Pirimicarb induced immune haemolytic anaemia in dogs.
Chart, IS; Garner, R; Jackson, JA; Sanderson, JH, 1977
)
2
" Both the histological study and the analysis of mortality show a direct relationship between the dosage and the effects of the pesticide."( The carbamate insecticide ZZ-Aphox induced structural changes of gills, liver, gall-bladder, heart, and notochord of Rana perezi tadpoles.
Alvarez, R; Paz Herráez, M; Pilar Honrubia, M, 1993
)
0.29
" No clinically significant depressions in blood cholinesterases were detected during the dosing study."( Biological monitoring for exposure to pirimicarb: method development and a human oral dosing study.
Jones, K; Patel, K; Sams, C, 2010
)
0.63
" Dose-response bioassays were conducted to determine relative tolerances to the insecticides pirimicarb, dimethoate, and imidacloprid; these results have been reported previously."( Relationship of insecticide tolerance to esterase enzyme activity in Aphis pomi and Aphis spiraecola (Hemiptera: Aphididae).
Foottit, RG; Lowery, DT; Smirle, MJ; Zurowski, CL, 2010
)
0.58
" In fat tissues, the key genes Lep, Nmb and Nmbr were altered in high dosed offspring, and were differentially expressed between sexes."( Effects on metabolic parameters in young rats born with low birth weight after exposure to a mixture of pesticides.
Axelstad, M; Christiansen, S; Hass, U; Mandrup, K; Ramhøj, L; Svingen, T; Vinggaard, AM, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (6)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
carbamate insecticideDerivatives of carbamic acid with insecticidal properties of general formula ROC(=O)NR(1)R(2), where ROH is an alcohol, oxime, or phenol and R(1) is hydrogen or methyl. Like organophosphate insecticides, they are cholinesterase inhibitors, but carbamate insecticides differ in action from the organophosphates in that the inhibitory effect on cholinesterase is generally brief.
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
insecticideStrictly, a substance intended to kill members of the class Insecta. In common usage, any substance used for preventing, destroying, repelling or controlling insects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
aminopyrimidineA member of the class of pyrimidines that is pyrimidine substituted by at least one amino group and its derivatives.
tertiary amino compoundA compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency23.94660.002541.796015,848.9004AID1347395; AID1347397; AID1347398; AID1347399
estrogen nuclear receptor alphaHomo sapiens (human)Potency50.11870.000229.305416,493.5996AID588514
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency25.11890.023723.228263.5986AID588543
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (105)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (8.57)18.7374
1990's18 (17.14)18.2507
2000's26 (24.76)29.6817
2010's42 (40.00)24.3611
2020's10 (9.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.33 (24.57)
Research Supply Index4.72 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index70.53 (26.88)
Search Engine Supply Index3.05 (0.95)

This Compound (34.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.91%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (0.91%)4.05%
Observational0 (0.00%)0.25%
Other108 (98.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]